Terms: = Sarcomas AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Clinical Outcome
15 results:
1. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/mdm2 axis.
Pasello M; Giudice AM; Cristalli C; Manara MC; Mancarella C; Parra A; Serra M; Magagnoli G; Cidre-Aranaz F; Grünewald TGP; Bini C; Lollini PL; Longhi A; Donati DM; Scotlandi K
Cell Oncol (Dordr); 2022 Dec; 45(6):1237-1251. PubMed ID: 36149602
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):1008-1018. PubMed ID: 33677797
[TBL] [Abstract] [Full Text] [Related]
3. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract] [Full Text] [Related]
5. mdm2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.
Varmazyar S; Marashi SM; Shoja Z; Tornesello ML; Buonaguro FM; Shahmahmoodi S; Safaie-Naraghi Z; Jalilvand S
Med Microbiol Immunol; 2017 Apr; 206(2):157-163. PubMed ID: 28083704
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of low-grade central osteosarcoma and role of CDK4 and mdm2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract] [Full Text] [Related]
7. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR
Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465
[TBL] [Abstract] [Full Text] [Related]
8. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic factors in the so-called malignant mesenchymoma: a clinicopathological and immunohistochemical analysis.
Adachi T; Oda Y; Sakamoto A; Terashi T; Tamiya S; Hachitanda Y; Tsuneyoshi M
Oncol Rep; 2003; 10(4):803-11. PubMed ID: 12792727
[TBL] [Abstract] [Full Text] [Related]
10. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract] [Full Text] [Related]
11. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors.
López-Guerrero JA; Pellín A; Noguera R; Carda C; Llombart-Bosch A
Lab Invest; 2001 Jun; 81(6):803-14. PubMed ID: 11406642
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities.
Shen J; Scotlandi K; Baldini N; Manara MC; Benini S; Cerisano V; Picci P; Serra M
Oncology; 2000 Apr; 58(3):253-60. PubMed ID: 10765129
[TBL] [Abstract] [Full Text] [Related]
13. Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology.
Layfield LJ; Liu K; Dodge R; Barsky SH
Arch Pathol Lab Med; 2000 Feb; 124(2):221-7. PubMed ID: 10656730
[TBL] [Abstract] [Full Text] [Related]
14. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract] [Full Text] [Related]
15. p53 mutation and mdm2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract] [Full Text] [Related]
